Acetaminophen hepatotoxicity: an updated review

Archives of Toxicology

Volumn 89, Issue 2, 2015, Pages 193-199

  Lancaster, Elizabeth M ^a   Hiatt, Jonathan R ^a   Zarrinpar, Ali ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acetaminophen; Acute liver failure; Drug toxicity; Liver transplantation

Indexed keywords

PARACETAMOL; ANALGESIC AGENT;

ACUTE LIVER FAILURE; CLINICAL FEATURE; HUMAN; LIVER SUPPORT; LIVER TOXICITY; LIVER TRANSPLANTATION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TOXIC HEPATITIS; CHEMICALLY INDUCED; LIVER FAILURE, ACUTE;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION;

EID: 84925519689     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-014-1432-2     Document Type: Review

References (42)

1. Bateman DN, Carroll R, Pettie J et al (2014a) Effect of the UK’s revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment. Br J Clin Pharmacol 78:610–618. doi:10.1111/bcp.12362
2. Bateman DN, Dear JW, Carroll R et al (2014b) Impact of reducing the threshold for acetylcysteine treatment in acute paracetamol poisoning: the recent United Kingdom experience. Clin Toxicol 52:868–872. doi:10.3109/15563650.2014.954125
3. Bateman DN, Dear JW, Thanacoody HK et al (2014c) Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial. Lancet 383:697–704. doi:10.1016/S0140-6736(13)62062-0
4. Bernuau J, Goudeau A, Poynard T et al (1986) Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6:648–651
5. Blieden M, Paramore LC, Shah D, Ben-Joseph R (2014) A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States. Expert Rev Clin Pharmacol 7:341–348. doi:10.1586/17512433.2014.904744
6. Bunchorntavakul C, Reddy KR (2013) Acetaminophen-related hepatotoxicity. Clin Liver Dis 17:587–607, viii. doi: 10.1016/j.cld.2013.07.005
7. Cholongitas E, Theocharidou E, Vasianopoulou P et al (2012) Comparison of the sequential organ failure assessment score with the King’s College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure. Liver Transpl 18:405–412. doi:10.1002/lt.23370
8. Chun LJ, Tong MJ, Busuttil RW, Hiatt JR (2009) Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol 43:342–349. doi:10.1097/MCG.0b013e31818a3854
9. Cooper SC, Aldridge RC, Shah T et al (2009) Outcomes of liver transplantation for paracetamol (acetaminophen)-induced hepatic failure. Liver Transpl 15:1351–1357. doi:10.1002/lt.21799
10. Court MH, Peter I, Hazarika S et al (2014) Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure. Drug Metab Dispos 42:28–32. doi:10.1124/dmd.113.053546
11. Craig DG, Ford AC, Hayes PC, Simpson KJ (2010a) Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther 31:1064–1076. doi:10.1111/j.1365-2036.2010.04279.x
12. Craig DG, Lee A, Hayes PC, Simpson KJ (2010b) Review article: the current management of acute liver failure. Aliment Pharmacol Ther 31:345–358. doi:10.1111/j.1365-2036.2009.04175.x
13. Craig DG, Bates CM, Davidson JS et al (2012) Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol 73:285–294. doi:10.1111/j.1365-2125.2011.04067.x
14. Dhawan A, Puppi J, Hughes RD, Mitry RR (2010) Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 7:288–298. doi:10.1038/nrgastro.2010.44
15. Feng HL, Li Q, Wang L et al (2014) Indocyanine green clearance test combined with MELD score in predicting the short-term prognosis of patients with acute liver failure. Hepatobiliary Pancreat Dis Int 13:271–275
16. Fontana RJ, Ellerbe C, Durkalski VE et al (2014) Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study. Liver Int. doi:10.1111/liv.12632
17. Heard KJ (2008) Acetylcysteine for acetaminophen poisoning. N Engl J Med 359:285–292. doi:10.1056/NEJMct0708278
18. Herrera MB, Fonsato V, Bruno S et al (2013) Human liver stem cells improve liver injury in a model of fulminant liver failure. Hepatology 57:311–319. doi:10.1002/hep.25986
19. Hwang JH, Kim YH, Noh JR et al (2014) The protective role of NAD(P)H:quinone oxidoreductase 1 on acetaminophen-induced liver injury is associated with prevention of adenosine triphosphate depletion and improvement of mitochondrial dysfunction. Arch Toxicol. doi:10.1007/s00204-014-1340-5
20. Izumi S, Langley PG, Wendon J et al (1996) Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure. Hepatology 23:1507–1511. doi:10.1002/hep.510230630
21. Jaeschke H, Williams CD, Ramachandran A, Bajt ML (2012) Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int 32:8–20. doi:10.1111/j.1478-3231.2011.02501.x
22. Karvellas CJ, Safinia N, Auzinger G et al (2010) Medical and psychiatric outcomes for patients transplanted for acetaminophen-induced acute liver failure: a case–control study. Liver Int 30:826–833. doi:10.1111/j.1478-3231.2010.02243.x
23. Larson AM, Polson J, Fontana RJ et al (2005) Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42:1364–1372. doi:10.1002/hep.20948
24. Lee KK, Imaizumi N, Chamberland SR et al (2014) Targeting mitochondria with methylene blue protects mice against acetaminophen-induced liver injury. Hepatology. doi:10.1002/hep.27385
25. Lodge JP, Dasgupta D, Prasad KR et al (2008) Emergency subtotal hepatectomy: a new concept for acetaminophen-induced acute liver failure: temporary hepatic support by auxiliary orthotopic liver transplantation enables long-term success. Ann Surg 247:238–249. doi:10.1097/SLA.0b013e31816401ec
26. Michaut A, Moreau C, Robin MA, Fromenty B (2014) Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease. Liver Int 34:e171–e179. doi:10.1111/liv.12514
27. Michna E, Duh MS, Korves C, Dahl JL (2010) Removal of opioid/acetaminophen combination prescription pain medications: assessing the evidence for hepatotoxicity and consequences of removal of these medications. Pain Med 11:369–378. doi:10.1111/j.1526-4637.2010.00811.x
28. Milesi-Halle A, Abdel-Rahman SM, Brown A et al (2011) Indocyanine green clearance varies as a function of N-acetylcysteine treatment in a murine model of acetaminophen toxicity. Chem Biol Interact 189:222–229. doi:10.1016/j.cbi.2010.12.001
29. Mowry JB, Spyker DA, Cantilena LR Jr et al (2013) 2012 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 30th Annual Report. Clin Toxicol 51:949–1229. doi:10.3109/15563650.2013.863906
30. Myers RP, Shaheen AA, Li B, et al (2008) Impact of liver disease, alcohol abuse, and unintentional ingestions on the outcomes of acetaminophen overdose. Clin Gastroenterol Hepatol 6:918–25; quiz 837. doi: 10.1016/j.cgh.2008.02.053
31. O’Grady J (2007) Modern management of acute liver failure. Clin Liver Dis 11:291–303. doi:10.1016/j.cld.2007.04.011
32. O’Grady J (2012) Liver transplantation for acute liver failure. Best Pract Res Clin Gastroenterol 26:27–33. doi:10.1016/j.bpg.2012.01.012
33. Possamai LA, McPhail MJ, Quaglia A et al (2013) Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure*. Crit Care Med 41:2543–2550. doi:10.1097/CCM.0b013e31829791a2
34. Possamai LA, McPhail MJ, Khamri W et al (2014) The role of intestinal microbiota in murine models of acetaminophen-induced hepatotoxicity. Liver Int. doi:10.1111/liv.12689
35. Rajput I, Prasad KR, Bellamy MC et al (2014) Subtotal hepatectomy and whole graft auxiliary transplantation for acetaminophen-associated acute liver failure. HPB 16:220–228. doi:10.1111/hpb.12124
36. Rumack BH, Peterson RC, Koch GG, Amara IA (1981) Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 141:380–385
37. Rutherford A, King LY, Hynan LS et al (2012) Development of an accurate index for predicting outcomes of patients with acute liver failure. Gastroenterology 143:1237–1243. doi:10.1053/j.gastro.2012.07.113
38. Schilling A, Corey R, Leonard M, Eghtesad B (2010) Acetaminophen: old drug, new warnings. Cleve Clin J Med 77:19–27. doi:10.3949/ccjm.77a.09084
39. Struecker B, Raschzok N, Sauer IM (2014) Liver support strategies: cutting-edge technologies. Nat Rev Gastroenterol Hepatol 11:166–176. doi:10.1038/nrgastro.2013.204
40. Suzuki A, Yuen N, Walsh J et al (2009) Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophen-associated liver injury. Clin Gastroenterol Hepatol 7:882–888. doi:10.1016/j.cgh.2009.03.034
41. Woolbright BL, McGill MR, Staggs VS et al (2014) Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients. Toxicol Sci. doi:10.1093/toxsci/kfu195
42. Zhao L, Pickering G (2011) Paracetamol metabolism and related genetic differences. Drug Metab Rev 43:41–52. doi:10.3109/03602532.2010.527984